Elevated levels of plasma phenylalanine in schizophrenia: A guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Okusaga, Olaoluwa ^a,b   Muravitskaja, Olesja ^a   Fuchs, Dietmar ^c   Ashraf, Ayesha ^a   Hinman, Sarah ^a   Giegling, Ina ^d   Hartmann, Annette M ^d   Konte, Bettina ^d   Friedl, Marion ^d   Schiffman, Jason ^e   Hong, Elliot ^a   Reeves, Gloria ^a   Groer, Maureen ^f   Dantzer, Robert ^g   Rujescu, Dan ^d,h   Postolache, Teodor T ^a,i  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF MARYLAND   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

ⁱ University of South Florida ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TYROSINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PROTEIN FUNCTION; SCHIZOPHRENIA;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GTP CYCLOHYDROLASE; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; PHENYLALANINE; SCHIZOPHRENIA; TYROSINE; YOUNG ADULT;

EID: 84893962700     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085945     Document Type: Article

References (36)

1. Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr Bull 35: 549-562.
2. van Spronsen FJ HM, Reijngoud DJ (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32: 46-51.
3. McTavish SF, McPherson MH, Harmer CJ, Clark L, Sharp T, et al. (2001) Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 179: 356-360. (Pubitemid 32996047)
4. Poisner AM (1960) Serum phenylalanine in schizophrenia: biochemical genetic aspects. J Nerv Ment Dis 131: 74-76.
5. Perry TL, Hansen S, Tischler B, Richards FM, Sokol M (1973) Unrecognized adult phenylketonuria. Implications for obstetrics and psychiatry. N Engl J Med 289: 395-398.
6. Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA (1985) Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry 147: 276-282. (Pubitemid 16255918)
7. Rao ML GG, Strebel B, Bräunig P, Huber G, Klosterkötter J (1990) Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Res 34: 243-257.
8. Potkin SG, Cannon-Spoor HE, DeLisi LE, Neckers LM, Wyatt RJ (1983) Plasma phenylalanine, tyrosine, and tryptophan in schizophrenia. Arch Gen Psychiatry 40: 749-752. (Pubitemid 13063230)
9. Smeraldi E, Lucca A, Macciardi F, Bellodi L (1987) Increased concentrations of various amino acids in schizophrenic patients. Evidence for heterozygosity effects? Hum Genet 76: 138-140.
10. Wei J XH, Ramchand CN, Hemmings GP (1995) Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset. Schizophr Res 14: 257-260.
11. Fuchs JE, Huber RG, von Grafenstein S, Wallnoefer HG, Spitzer GM, et al. (2012) Dynamic regulation of phenylalanine hydroxylase by simulated redox manipulation. PLoS One 7: e53005.
12. Bilder DA, Burton BK, Coon H, Leviton L, Ashworth J, et al. (2013) Psychiatric symptoms in adults with phenylketonuria. Mol Genet Metab 108: 155-160.
13. Blau N, Tḧony B, Cotton, RG H, Hyland K (2001) Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet, A L., Sly, W S., Valle, D and Vogelstein, B, editor. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill. 1725-1776.
14. Werner ER, Blau N, Thony B (2011) Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 438: 397-414.
15. Richardson MA, Read LL, Reilly MA, Clelland JD, Clelland CL (2007) Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder. Neurochem Res 32: 107-113. (Pubitemid 46020936)
16. Richardson MA, Read LL, Taylor Clelland CL, Reilly MA, Chao HM, et al. (2005) Evidence for a tetrahydrobiopterin deficit in schizophrenia. Neuropsychobiology 52: 190-201. (Pubitemid 41677018)
17. Okusaga O, Yolken RH, Langenberg P, Sleemi A, Kelly DL, et al. (2013) Elevated gliadin antibody levels in individuals with schizophrenia. World J Biol Psychiatry 14: 509-515.
18. First MB, Spitzer, Robert L, Gibbon Miriam, and Williams, Janet B.W (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute.
19. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276. (Pubitemid 18039085)
20. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC (2010) Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 67: 255-262.
21. Neurauter G, Grahmann AV, Klieber M, Zeimet A, Ledochowski M, et al. (2008) Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. Cancer Lett 272: 141-147.
22. Hoekstra R, van den Broek WW, Fekkes D, Bruijn JA, Mulder PG, et al. (2001) Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression. Psychiatry Res 103: 115-123. (Pubitemid 32817073)
23. Leucht S KJ, Kissling W, Hamann J, Etschel E, Engel RR (2005) What does the PANSS mean? Schizophr Res 79: 231-238. (Pubitemid 41457263)
24. Teraishi T, Ozeki Y, Hori H, Sasayama D, Chiba S, et al. (2012) 13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients. Transl Psychiatry 2: e119.
25. Zangerle R, Kurz K, Neurauter G, Kitchen M, Sarcletti M, et al. (2010) Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy. Brain Behav Immun 24: 403-408.
26. Ploder M, Neurauter G, Spittler A, Schroecksnadel K, Roth E, et al. (2008) Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrations. Amino Acids 35: 303-307.
27. Zoller H SA, Schroecksnadel S, Vogel W, Fuchs D (2012) Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio. J Interferon Cytokine Res 32: 216-220.
28. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70: 663-671.
29. Murr C, Widner B, Wirleitner B, Fuchs D (2002) Neopterin as a marker for immune system activation. Curr Drug Metab 3: 175-187. (Pubitemid 34326529)
30. Milstien S, Katusic Z (1999) Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263: 681-684. (Pubitemid 29490686)
31. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, et al. (2001) Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288. (Pubitemid 32221353)
32. Couce ML, Boveda MD, Valerio E, Perez-Munuzuri A, Fraga JM (2012) Long-term pharmacological management of phenylketonuria, including patients below the age of 4 years. JIMD Rep 2: 91-96.
33. Lopansri BK, Anstey NM, Stoddard GJ, Mwaikambo ED, Boutlis CS, et al. (2006) Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications. Infect Immun 74: 3355-3359. (Pubitemid 43794524)
34. Wurtman RJ, Rose CM, Chou C, Larin FF (1968) Daily Rhythms in the Concentrations of Various Amino Acids in Human Plasma. N Engl J Med 279: 171-175.
35. Maher TJ, Glaeser BS, Wurtman RJ (1984) Diurnal variations in plasma concentrations of basic and neutral amino acids and in red cell concentrations of aspartate and glutamate: effects of dietary protein intake. Am J Clin Nutr 39: 722-729. (Pubitemid 14101227)
36. Leeming RJ, Blair JA, Green A, Raine DN (1976) Biopterin derivatives in normal and phenylketonuric patients after oral loads of L-phenylalanine, Ltyrosine, and L-tryptophan. Arch Dis Child 51: 771-777.